Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesare Sarrecchia

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|January 21, 2021
Atorvastatin-Associated GynecomastiaGiuseppe Famularo, Cesare Sarrecchia
Expert Review of Anti-Infective Therapy|April 30, 2009
Aciclovir, herpes viruses and HIV: a never-ending storyAntonio Volpi, Cesare Sarrecchia, Pasquale Sordillo
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 1, 2005
HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAbCesare Sarrecchia, Alessandra Cappelli, Pasquale Aiello
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 8, 2008
Multidrug resistance after lamivudine therapy for chronic hepatitis BCesare Sarrecchia, Antonio Volpi, Pasquale Sordillo, et al.
Medicine|October 21, 2016
Epidemiological burden estimates for pathologies with a nonconstant risk: an application to HCV in Italy according to age, Metavir score, and genotype: A systematic review and meta-analysisRossella Letizia Mancusi, Massimo Andreoni, Daniela d'Angela, et al.
The Journal of Infection|December 6, 2011
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapyLaura Ceccarelli, Romina Salpini, Loredana Sarmati, et al.
Plos One|March 30, 2018
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearanceVincenzo Malagnino, Romina Salpini, Gaetano Maffongelli, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 10, 2013
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosisClaudia Matteucci, Roberta Sorrentino, Lia Bellis, et al.
Plos One|July 14, 2012
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitorsValeria Cento, Carmen Mirabelli, Romina Salpini, et al.
Antiviral Research|November 17, 2011
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detectionValentina Svicher, Valeria Cento, Martina Bernassola, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|January 21, 2021
Atorvastatin-Associated GynecomastiaGiuseppe Famularo, Cesare Sarrecchia
Expert Review of Anti-Infective Therapy|April 30, 2009
Aciclovir, herpes viruses and HIV: a never-ending storyAntonio Volpi, Cesare Sarrecchia, Pasquale Sordillo
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 1, 2005
HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAbCesare Sarrecchia, Alessandra Cappelli, Pasquale Aiello
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 8, 2008
Multidrug resistance after lamivudine therapy for chronic hepatitis BCesare Sarrecchia, Antonio Volpi, Pasquale Sordillo, et al.
Medicine|October 21, 2016
Epidemiological burden estimates for pathologies with a nonconstant risk: an application to HCV in Italy according to age, Metavir score, and genotype: A systematic review and meta-analysisRossella Letizia Mancusi, Massimo Andreoni, Daniela d'Angela, et al.
The Journal of Infection|December 6, 2011
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapyLaura Ceccarelli, Romina Salpini, Loredana Sarmati, et al.
Plos One|March 30, 2018
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearanceVincenzo Malagnino, Romina Salpini, Gaetano Maffongelli, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 10, 2013
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosisClaudia Matteucci, Roberta Sorrentino, Lia Bellis, et al.
Plos One|July 14, 2012
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitorsValeria Cento, Carmen Mirabelli, Romina Salpini, et al.
Antiviral Research|November 17, 2011
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detectionValentina Svicher, Valeria Cento, Martina Bernassola, et al.
Pageof 2